Document 0242 DOCN M95B0242 TI Case report: vitamin D-mediated hypercalcemia in fungal infections. DT 9511 AU Spindel SJ; Hamill RJ; Georghiou PR; Lacke CE; Green LK; Mallette LE; Section of Infectious Disease, Veterans Affairs Medical Center,; Houston, TX 77030, USA. SO Am J Med Sci. 1995 Aug;310(2):71-6. Unique Identifier : AIDSLINE MED/95358162 AB Hypercalcemia has been well described in a variety of neoplastic and granulomatous diseases. One mechanism for this hypercalcemia is via the excess production of 1,25-dihydroxyvitamin D from extra-renal sources. The authors describe an AIDS patient infected with Cryptococcus neoformans who had suggestive evidence of vitamin D-mediated hypercalcemia. He had an elevated serum 1,25-dihydroxyvitamin D value, a normal 25-hydroxyvitamin D value, and low values for parathyroid hormone and parathyroid hormone-related peptide. Most previously reported cases of hypercalcemia associated with fungal infections did not include sufficient evidence to implicate a role for excess 1,25-dihydroxyvitamin D production, except for two case reports involving patients with hypercalcemia with infections due to Pneumocystis carinii and Candida albicans. The authors' patient's hypercalcemia resolved during treatment of his underlying infection. Patients with hypercalcemia or in whom hypercalcemia develops during a disseminated fungal infection should have vitamin D metabolites measured as part of their work-up. DE Acquired Immunodeficiency Syndrome/*COMPLICATIONS/METABOLISM Adult AIDS-Related Opportunistic Infections/COMPLICATIONS/*METABOLISM Calcitriol/BLOOD Case Report Cryptococcosis/COMPLICATIONS/*METABOLISM Human Hypercalcemia/BLOOD/*ETIOLOGY Male Support, U.S. Gov't, Non-P.H.S. Support, U.S. Gov't, P.H.S. Vitamin D/*METABOLISM JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).